This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of testis
C3_TESTIS
testicular carcinoma: A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
639 |
4. Check minimum number of eventsNone |
639 |
5. Include endpointsNone |
639 |
6. Filter based on genotype QC (FinnGen only) |
606 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of testis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of testis, including Hilmo
- malignant neoplasm of male genital organs
- Solid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 606 | - | 606 |
| Unadjusted period prevalence (%) | 0.28 | - | 0.28 |
| Median age at first event (years) | 35.96 | - | 35.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 639
- Matched controls
- 6390
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
644.2
307.7
385
15
KFC00
NOMESCO Finland
Unilateral orchiectomy
924.0
307.7
462
18
JN4BD
NOMESCO Finland
Extensive body CT
35.5
307.7
252
115
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
296.7
261
*
A03FA01
ATC
metoclopramide; systemic, rectal
18.8
273.0
262
228
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
257.2
229
*
130
Kela drug reimbursment
Malignant tumour
+∞
235.4
211
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
19.2
210.1
184
132
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
178.8
163
*
JN4AD
NOMESCO Finland
Body CT examination
17.0
173.7
159
122
H02AB02
ATC
dexamethasone; systemic
46.7
165.7
99
25
A04AA01
ATC
ondansetron; systemic, rectal
32.5
146.4
97
35
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1533.5
132.1
124
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
107.4
100
*
A04AA02
ATC
granisetron; systemic, transdermal
1125.6
101.0
96
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
98.5
92
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
33.5
89.4
58
19
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
176.4
88.7
91
6
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
83.2
78
*
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
82.1
77
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
78.8
74
*
L03AA02
ATC
filgrastim; parenteral
179.9
77.0
79
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
75.4
389
1660
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
74.5
70
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
24.6
69.4
50
22
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
62.5
59
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
60.9
287
1111
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
59.3
56
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.5
59.3
132
288
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
168.2
59.0
61
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
58.2
55
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.9
57.2
115
228
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
56.1
53
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
49.6
47
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.6
46.7
70
102
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
45.4
43
*
L03AA13
ATC
pegfilgrastim; parenteral
241.6
44.5
45
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
44.3
42
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
161.1
43.4
45
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
43.2
41
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
42.1
40
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
42.1
40
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
40.0
38
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
411.6
39.5
39
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
39.0
37
*
N02AA05
ATC
oxycodone; systemic
4.5
38.9
107
274
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
38.4
203
807
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
37.9
36
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
37.5
117
329
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
36.8
35
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
56.0
35.9
42
8
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
35.8
34
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
35.8
34
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
35.8
34
*
ZXE00
NOMESCO Finland
One hour or less
2.8
33.7
261
1267
Z51.5
ICD-10 Finland
Palliative care
9.3
33.1
41
47
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.0
32.7
106
305
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
32.6
31
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
339.8
32.2
32
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.9
31.3
44
59
WF049
NOMESCO Finland
Radiotherapy of metastasis
328.2
31.1
31
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
168.1
31.0
32
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
29.4
28
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
29.4
28
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
29.4
28
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
29.4
28
*
Y05
ICPC
Scrotum/testis sympt/compl other
8.2
28.8
39
50
WW500
NOMESCO Finland
Blood transfusion
10.2
28.8
33
34
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
28.3
27
*
WX402
NOMESCO Finland
General anaesthesia
3.0
27.1
149
593
WX320
NOMESCO Finland
Spinalanesthesy
2.9
26.2
150
610
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
5.1
25.0
55
116
E29.1
ICD-10 Finland
Testicular hypofunction
6.1
24.9
45
79
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
24.1
23
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
23.8
221
1135
B01AB10
ATC
tinzaparin; parenteral
4.7
23.6
57
130
Y78
ICPC
Malign neopl male genital other
+∞
23.1
22
*
L01BC06
ATC
capecitabine; oral
+∞
23.1
22
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.8
23.0
43
78
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
22.0
21
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
22.0
21
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
22.0
21
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.0
21.9
34
51
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
21.6
80
250
DFF00
NOMESCO Finland
Pure tone audiometry
3.5
21.0
78
244
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
20.9
20
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.9
20
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
9.0
20.8
26
30
JN4CD
NOMESCO Finland
Very extensive body CT
17.7
20.7
32
19
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
20.1
54
134
WZC30
NOMESCO Finland
Teaching
3.0
19.7
100
377
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
108.4
19.7
21
*
B01AB05
ATC
enoxaparin; parenteral
2.5
19.4
154
728
D29.2
ICD-10 Finland
Benign neoplasm: Testis
47.6
19.3
23
5
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
19.2
215
1178
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.8
18
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
18.8
18
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.8
18.1
101
400
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
17.8
17
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
17.8
17
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
17.8
17
*
116
Kela drug reimbursment
Prostate cancer
+∞
17.8
17
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
17.2
535
4284
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.8
17.1
24
32
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.7
16
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
16.7
16
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
ZX120
NOMESCO Finland
Intravenous
3.5
16.6
59
179
XW000
NOMESCO Finland
Bone marrow biopsy
6.4
16.0
27
44
A04AD12
ATC
aprepitant; systemic
+∞
15.7
15
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
15.7
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.7
15
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
15.7
15
*
N46
ICD-10 Finland
Male infertility
4.3
15.6
41
100
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.9
15.4
24
36
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
14.6
105
469
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
82.0
14.6
16
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
13.6
13
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
142.9
13.5
14
*
JN6AD
NOMESCO Finland
CT of torso and neck
26.4
13.4
18
7
KF8AE, ,
SPAT
4.9
13.2
29
61
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.5
12
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
12.5
12
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.3
12.2
15
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
12.1
104
501
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.4
12.1
24
46
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
11.9
61
230
ZX090
NOMESCO Finland
Other technic of radiotherapy
66.2
11.6
13
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.5
11.6
40
119
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.5
11
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
11.5
11
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
11.5
11
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
11.5
11
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.4
129
693
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
11.4
108
542
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.6
11.4
24
29
R50.9
ICD-10 Finland
Fever, unspecified
2.2
11.3
102
501
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
11.2
32
83
B01AB04
ATC
dalteparin; parenteral
4.4
10.9
27
63
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
10.8
59
230
7513
FHL
Test prosthesis installation
61.0
10.7
12
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
10.7
27
64
N50.9
ICD-10 Finland
Disorder of male genital organs, unspecified
8.7
10.6
22
26
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.6
10.6
25
56
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
10.4
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
A02BC02
ATC
pantoprazole; systemic
1.7
10.1
359
2729
KFA00
NOMESCO Finland
Exploration of testis
8.9
9.8
20
23
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
9.7
32
92
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.6
234
1598
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
30.5
9.4
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
9.4
9
*
WX702
NOMESCO Finland
Supraglottic ventilation device
3.1
9.3
39
131
J01MA12
ATC
levofloxacin; systemic
2.1
9.3
93
476
ZXA05
NOMESCO Finland
Left side
1.9
9.2
128
737
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
37.2
9.0
11
*
R4190
NOMESCO Finland
Nutritional therapy
4.3
9.0
23
55
KA1FN
NOMESCO Finland
Isotope renography
18.9
9.0
13
7
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
8.8
38
130
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.3
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.3
8
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
8.3
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
Y77
ICPC
Malignant neoplasm prostate
+∞
8.3
8
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
8.3
8
*
M04AA01
ATC
allopurinol; systemic
2.2
8.3
77
381
R4110
NOMESCO Finland
Physiotherapy
1.8
8.3
139
846
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
8.3
44
169
KFB00
NOMESCO Finland
Biopsy of testis
17.4
8.1
12
7
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.1
8.1
16
18
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
7.9
55
241
Y28
ICPC
Limited function/disability (Y)
11.0
7.8
14
13
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
7.8
34
117
C03CA01
ATC
furosemide; systemic
1.8
7.7
119
705
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
7.7
48
200
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.7
163
1062
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
12.0
7.6
13
11
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
81.0
7.4
8
*
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
4.1
7.4
20
50
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
7.3
7
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
7.3
7
*
ZXA00
NOMESCO Finland
Right side
1.8
7.1
128
793
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.7
6.9
15
20
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
6.9
38
149
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
40.5
6.8
8
*
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
16.9
6.8
10
6
WX882
NOMESCO Finland
High dependency care
3.7
6.5
20
55
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.5
90
514
A02BX02
ATC
sucralfate; oral
4.0
6.5
18
46
WX892
NOMESCO Finland
Monitored bed care
2.3
6.4
47
211
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
11.2
6.3
11
10
XX9XW, ,
NOMESCO Finland
9.4
6.3
12
13
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.3
419
3524
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
1869C
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),MUU TAI TARK MÄÄRITT]
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
1860A
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOPL MAL TESTIS (ABDOMIN/INGUIN),SEMINOMA]
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
9680/3-C62.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of descended testis
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
6.2
24
77
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.3
6.0
17
33
UJF32
NOMESCO Finland
Coloscopy
1.7
6.0
113
707
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
363
15
558.97
307.65
9.6
1.1
1673.91
—
u/l
—
121
0
176
10
242.52
307.65
10.2
1.1
—
—
—
0
0
150
80
24.19
196.87
3.2
1.5
15.93
7.06
iu/l
5.76
121
63
193
201
13.32
174.98
3.0
1.5
7.35
4.05
u/l
6.96
163
171
288
806
5.68
102.01
4.1
2.4
13.42
15.33
nmol/l
4.49
277
752
454
2019
5.31
87.12
10.1
4.5
10.80
12.98
umol/l
5.26
449
1930
536
3271
4.96
55.31
12.6
5.9
76.50
74.34
u/l
0.73
527
3094
440
2468
3.51
48.54
12.7
8.2
3.62
4.18
e9/l
5.90
399
2161
255
1077
3.28
44.57
5.5
2.0
2.36
2.35
mmol/l
0.61
232
945
161
559
3.51
37.94
6.0
2.0
2.43
2.42
mmol/l
1.24
145
477
307
1579
2.82
35.93
2.9
2.4
—
—
—
0
0
244
1126
2.89
34.90
3.4
2.8
61.72
110.83
e6/l
0.30
188
869
227
1019
2.90
34.05
3.2
2.8
0.54
0.29
e6/l
0.49
175
769
307
1627
2.71
33.19
9.5
4.4
36.53
37.06
g/l
0.85
287
1506
269
1369
2.67
31.08
3.4
2.9
—
—
—
0
0
392
2454
2.55
28.50
6.1
4.8
6.63
6.80
mmol/l
0.74
377
2315
316
1798
2.50
28.18
10.3
6.3
1.20
1.20
mmol/l
0.50
250
1556
66
148
4.86
28.00
5.7
2.0
4.46
2.47
ug/l
2.03
51
120
353
2162
2.41
26.09
6.4
6.4
26.74
28.68
%
2.77
341
2059
287
1615
2.41
25.56
9.1
6.1
1.21
1.20
mmol/l
0.37
280
1478
142
592
2.80
23.46
3.1
2.6
0.40
0.53
e6/l
0.32
84
319
145
625
2.71
22.37
3.0
2.5
0.91
0.91
e6/l
0.01
88
352
340
2141
2.26
22.35
6.2
6.2
57.77
56.22
%
1.58
329
2044
200
1023
2.39
21.38
5.3
4.0
91.95
87.27
%
2.09
195
1003
289
1782
2.14
19.13
15.9
14.5
1.28
1.30
inr
0.10
86
534
556
4499
2.82
18.09
20.5
9.5
90.56
89.74
ml/min/173m2
0.33
503
3678
206
1135
2.20
17.97
3.4
2.4
2156.99
6974.41
umol/l
1.31
195
1028
161
801
2.35
17.93
2.8
2.3
—
—
—
0
0
153
745
2.39
17.89
2.8
2.3
3.15
2.49
e6/l
0.45
137
674
569
4748
2.81
15.73
23.0
12.5
139.40
139.75
mmol/l
3.66
559
4613
19
5
39.10
15.46
1.2
1.0
—
—
—
0
0
166
887
2.18
15.30
1.7
1.9
1.34
0.98
mg/l
0.96
126
626
30
57
5.47
15.27
1.9
1.9
—
—
—
0
0
569
4772
2.76
15.11
23.4
12.5
3.98
4.00
mmol/l
1.01
558
4633
122
592
2.31
14.11
2.6
1.8
—
—
—
0
0
34
78
4.55
13.96
2.0
1.8
—
—
—
0
0
111
522
2.36
13.78
10.3
7.5
104.48
104.26
mmol/l
0.24
111
522
34
81
4.38
13.32
2.0
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
104
3.93
13.18
3.5
3.1
0.27
0.32
u/ml
0.64
20
55
564
4796
2.50
12.97
21.0
10.6
22.97
24.13
mg/l
0.38
480
3622
85
387
2.38
11.27
4.0
2.9
—
—
—
0
0
31
79
4.07
11.14
2.7
4.2
57.77
55.90
%
0.43
31
79
24
53
4.67
10.32
2.2
2.0
—
—
—
0
0
24
53
4.67
10.32
2.2
2.0
—
—
—
0
0
591
5260
2.65
10.12
14.9
8.1
32.50
33.99
u/l
1.14
586
5100
29
78
3.85
9.70
2.7
4.2
4.03
4.25
e9/l
0.20
29
78
34
104
3.40
9.43
6.5
5.8
861.50
652.08
iu/ml
—
6
13
86
426
2.18
9.30
2.6
1.7
—
—
—
0
0
106
572
2.02
9.15
3.2
2.4
12.90
14.71
umol/l
1.69
99
531
59
256
2.44
8.67
2.1
1.6
—
—
—
0
0
15
14
10.94
8.33
2.9
1.1
184.13
166.29
u/l
0.82
15
14
84
436
2.07
8.03
2.6
1.8
—
—
—
0
0
19
43
4.52
7.94
1.6
2.2
—
—
—
0
0
92
498
1.99
7.83
3.5
2.5
24.45
26.36
%
0.70
79
435
260
1902
1.62
7.82
3.0
2.9
0.01
0.00
estimate
0.36
71
343
258
1892
1.61
7.64
4.4
4.0
0.00
0.00
estimate
-0.00
70
337
25
72
3.57
7.61
2.2
3.1
—
481.63
—
0
8
483
4129
1.70
7.48
26.9
13.0
14.11
15.29
%
0.54
476
4045
95
531
1.93
7.36
3.4
2.4
2.24
2.28
g/l
0.25
88
494
53
243
2.29
6.90
1.6
1.4
—
—
—
0
0
257
1917
1.57
6.90
3.0
2.9
0.00
0.00
estimate
-0.00
64
305
23
67
3.52
6.90
1.3
1.4
—
—
—
0
0
48
215
2.33
6.60
2.1
1.6
—
—
—
0
0
17
41
4.23
6.58
1.2
1.2
—
—
—
0
0
81
450
1.92
6.38
5.4
2.5
12.46
9.41
umol/l
0.33
72
399
19
52
3.74
6.24
1.5
1.7
—
—
—
0
0
182
1290
1.57
5.93
3.4
2.5
52.84
62.17
u/l
1.58
166
1215
312
2494
1.49
5.75
4.2
3.2
1.79
1.62
ug/l
0.38
277
2267
16
31
5.27
5.73
2.0
1.5
0.14
0.15
nmol/l
0.16
16
24
17
46
3.77
5.68
1.6
1.6
—
—
—
0
0
72
403
1.89
5.54
3.6
2.4
30.02
153.64
u/l
0.55
59
353
10
10
10.14
5.54
2.3
1.3
—
—
—
0
0
10
10
10.14
5.54
2.3
1.3
—
—
—
0
0
10
10
10.14
5.54
2.3
1.3
—
—
—
0
0
16
35
4.66
5.20
2.2
1.7
—
—
—
0
0
72
413
1.84
5.14
5.0
3.4
1.36
1.88
mmol/l
0.75
62
338
72
415
1.83
5.06
5.0
3.4
5.79
5.94
kpa
0.66
72
400
15
32
4.77
5.02
2.3
1.7
—
—
—
0
0
20
66
3.10
4.98
1.5
1.7
—
—
—
0
0
17
51
3.40
4.91
1.6
1.6
—
—
—
0
0
10
13
7.79
4.86
2.3
1.5
—
—
—
0
0
10
13
7.79
4.86
2.3
1.5
—
—
—
0
0
26
101
2.64
4.86
1.4
1.6
—
—
—
0
0
601
5646
2.08
4.77
31.9
15.1
232.86
239.00
e9/l
1.90
587
5503
601
5650
2.07
4.69
32.5
15.3
41.24
43.66
%
2.20
580
5312
30
128
2.41
4.64
3.0
1.7
—
—
—
0
0
21
75
2.86
4.59
1.5
1.7
—
—
—
0
0
7
5
14.13
4.58
1.0
1.0
—
—
—
0
0
601
5659
2.04
4.53
31.8
15.1
4.67
4.83
e12/l
9.40
585
5503
22
82
2.74
4.46
1.5
1.5
245.58
320.13
ug/g
0.58
12
49
199
1520
1.45
4.34
3.1
2.9
—
—
—
0
0
14
41
3.47
4.20
2.2
2.1
—
—
—
0
0
14
41
3.47
4.20
2.2
2.1
—
—
—
0
0
119
831
1.53
4.02
2.5
2.1
2.91
2.82
mg/l
0.17
100
705
26
112
2.38
3.97
2.4
1.6
—
—
—
0
0
21
82
2.61
3.92
2.7
2.5
131.69
137.61
g/l
0.32
13
60
364
3132
1.38
3.82
4.0
3.6
12.04
8.45
mm/h
3.74
338
2916
16
55
2.96
3.76
1.2
1.7
—
—
—
0
0
141
1036
1.46
3.71
3.2
3.2
1127.64
1403.37
ng/l
0.50
120
855
10
20
5.06
3.70
1.3
1.7
—
—
—
0
0
55
323
1.77
3.67
2.0
2.1
70.42
69.56
ml/min/173m2
0.03
19
120
9
16
5.69
3.67
1.3
1.9
—
—
—
0
0
9
16
5.69
3.67
1.3
1.9
—
—
—
0
0
14
40
3.55
3.62
2.6
2.5
527.86
783.08
e6/l
1.45
14
40
73
466
1.64
3.61
11.5
9.4
0.69
1.20
mmol/l
0.69
61
372
6
6
10.08
3.50
2.7
1.2
11.00
11.90
u/l
—
6
6
41
223
1.90
3.50
5.8
3.6
23.63
24.29
mmol/l
0.78
41
218
207
1648
1.38
3.44
3.7
3.3
52.16
52.92
ng/l
0.01
153
1061
19
77
2.51
3.32
1.4
1.3
—
—
—
0
0
19
77
2.51
3.32
1.4
1.3
—
—
—
0
0
11
28
3.98
3.30
2.4
1.3
—
—
—
0
0
11
28
3.98
3.30
2.4
1.3
—
—
—
0
0
11
28
3.98
3.30
2.4
1.3
—
—
—
0
0
61
385
1.65
3.17
13.0
10.7
120.33
129.16
g/l
2.36
61
373
47
279
1.74
3.06
3.1
2.8
126.02
137.07
g/l
1.85
47
273
45
266
1.74
2.97
3.7
2.9
0.78
1.71
mmol/l
1.10
34
187
35
192
1.87
2.94
3.5
2.4
0.10
0.14
e6/l
0.28
35
187
59
377
1.62
2.93
2.3
1.8
372.06
360.81
nmol/l
0.19
54
350
42
248
1.74
2.80
1.4
1.4
—
—
—
0
0
10
29
3.49
2.70
1.4
1.6
—
—
—
0
0
9
24
3.79
2.68
1.3
2.2
—
—
—
0
0
35
199
1.80
2.65
4.1
3.1
23.71
24.96
mmol/l
1.54
35
191
30
164
1.87
2.58
2.2
2.9
5.13
4.82
pmol/l
0.40
25
149
5
7
7.19
2.55
1.0
1.1
—
—
—
0
0
6
11
5.50
2.55
1.0
1.4
—
—
—
0
0
11
37
3.01
2.50
1.4
1.1
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
14
57
2.49
2.46
1.1
1.1
—
—
—
0
0
12
45
2.70
2.46
2.1
2.9
39543.92
42471.11
ug/l
0.10
12
45
10
32
3.16
2.44
3.7
2.1
—
—
—
0
0
11
38
2.93
2.42
1.7
2.1
—
—
—
0
0
66
454
1.51
2.41
3.7
4.2
28.52
29.40
%
0.24
50
342
192
1583
1.30
2.40
5.0
3.1
37.50
36.39
u/l
0.10
185
1499
17
79
2.18
2.26
3.5
2.7
16.93
17.18
%
0.08
12
46
468
4991
0.77
2.25
4.3
4.3
2.84
2.84
mmol/l
0.01
441
4714
52
346
1.55
2.22
4.5
2.7
5.30
4.72
kpa
0.95
52
330
11
41
2.71
2.21
1.1
1.0
—
—
—
0
0
172
1411
1.30
2.21
2.5
2.3
0.69
0.69
ug/l
0.02
112
778
12
49
2.48
2.11
3.2
2.7
—
—
—
0
0
18
90
2.03
2.02
1.2
1.2
—
—
—
0
0
86
647
1.38
1.98
2.0
1.7
1061.42
1164.15
nmol/l
0.57
61
509
28
164
1.74
1.98
6.8
7.2
1.72
1.69
%
0.03
28
152
17
85
2.03
1.92
1.9
1.3
56.02
49.85
mg/l
0.15
12
65
25
144
1.77
1.87
1.1
1.2
—
—
—
0
0
17
86
2.00
1.86
1.9
1.3
45.77
36.03
mg/l
0.28
12
67
11
46
2.42
1.86
1.3
1.1
—
—
—
0
0
15
73
2.08
1.82
1.1
1.7
—
—
—
0
0
463
4908
0.79
1.81
4.0
3.9
1.24
1.28
mmol/l
1.64
433
4641
466
4934
0.79
1.79
4.1
4.0
4.63
4.61
mmol/l
0.19
438
4682
14
67
2.11
1.77
2.4
1.4
7.00
7.05
u/ml
—
7
37
122
986
1.29
1.74
3.3
3.2
0.03
0.01
estimate
0.23
66
313
7
24
2.94
1.72
1.9
2.1
—
—
—
0
0
13
62
2.12
1.66
1.2
1.1
—
—
—
0
0
175
1489
1.24
1.63
1.9
1.8
92.18
94.68
pmol/l
0.28
101
832
5
14
3.59
1.62
8.0
2.0
—
—
—
0
0
20
115
1.76
1.54
1.3
1.3
128.06
194.83
pmol/l
1.19
20
115
16
86
1.88
1.51
3.8
2.8
1.35
1.66
mmol/l
1.13
16
81
7
28
2.52
1.45
1.6
2.2
—
—
—
0
0
181
1564
1.22
1.45
3.6
2.5
200.15
169.65
ug/l
0.97
163
1453
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
23
141
1.65
1.43
1.1
1.2
274.94
268.38
u/ml
0.04
17
84
30
197
1.55
1.43
5.0
3.3
52.60
52.75
%
0.01
30
192
19
111
1.73
1.40
1.1
1.2
566.79
536.66
mg/l
0.21
19
104
9
41
2.21
1.37
3.4
4.0
—
—
—
0
0
9
41
2.21
1.37
2.0
1.1
—
—
—
0
0
9
41
2.21
1.37
2.0
1.2
—
—
—
0
0
9
41
2.21
1.37
2.0
1.1
—
—
—
0
0
9
41
2.21
1.37
2.0
1.1
—
—
—
0
0
98
797
1.27
1.35
1.5
1.5
18.94
19.16
nmol/l
0.06
86
688
22
136
1.64
1.34
2.2
3.9
—
—
—
0
0
9
42
2.16
1.34
2.0
1.2
—
—
—
0
0
9
42
2.16
1.34
2.0
1.1
—
—
—
0
0
9
43
2.11
1.30
1.1
1.2
—
—
—
0
0
16
91
1.78
1.30
1.2
1.2
3.66
3.83
mmol/l
0.36
16
85
15
84
1.80
1.28
1.7
1.2
—
—
—
0
0
98
804
1.26
1.26
1.8
2.2
—
—
—
0
0
8
39
2.06
1.15
1.6
1.4
1.21
1.03
g/l
—
8
39
5
20
2.51
1.15
1.0
1.7
—
—
—
0
0
453
4745
0.84
1.14
3.6
3.6
1.48
1.42
mmol/l
0.91
420
4473
7
30
2.35
1.12
1.3
1.0
—
—
—
0
0
100
835
1.23
1.12
4.1
3.4
509.32
934.88
ng/l
0.87
77
614
19
292
0.64
1.12
1.3
1.6
—
—
—
0
0
220
1977
1.17
1.11
3.4
3.1
22.62
23.81
%
0.42
90
716
89
734
1.25
1.11
1.8
2.2
—
—
—
0
0
33
235
1.43
1.11
7.1
4.4
132.85
92.01
ng/l
1.39
26
213
327
3034
1.16
1.09
3.2
2.7
14.97
14.94
pmol/l
0.08
294
2762
9
52
1.74
0.92
1.1
1.0
—
—
—
0
0
8
42
1.92
0.89
1.0
1.4
—
—
—
0
0
8
42
1.92
0.89
1.0
1.2
—
—
—
0
0
413
4320
0.88
0.86
5.6
5.1
39.57
39.56
mmol/mol
0.00
378
4089
22
300
0.72
0.75
2.7
2.4
31.32
14.64
au/ml
—
5
31
44
544
0.79
0.75
1.2
1.2
3.29
8.89
u/ml
1.14
12
226
432
4487
0.89
0.74
4.2
3.8
6.03
5.98
mmol/l
0.25
393
4149
5
25
2.01
0.73
2.0
2.2
—
—
—
0
0
12
76
1.59
0.72
1.2
1.1
—
—
—
0
0
5
27
1.86
0.68
3.0
1.1
—
—
—
0
0
7
42
1.67
0.68
1.1
1.0
—
—
—
0
0
17
119
1.44
0.67
1.9
2.0
—
—
—
0
0
7
43
1.63
0.67
1.0
1.1
272.86
283.74
mg/l
—
7
34
409
3926
1.12
0.66
3.8
3.4
1.83
2.17
mu/l
0.57
370
3613
19
138
1.39
0.63
1.2
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
8
52
1.55
0.59
1.0
1.0
—
—
—
0
0
19
140
1.37
0.59
1.2
1.1
—
—
—
0
0
6
35
1.72
0.58
1.7
1.7
—
2637166.67
—
0
6
87
980
0.87
0.57
1.3
1.2
4.56
1.58
u/ml
0.48
24
297
53
621
0.84
0.56
1.1
1.2
15.05
24.31
iu/ml
1.55
16
181
20
150
1.34
0.56
1.5
1.8
—
—
—
0
0
8
55
1.46
0.56
1.1
1.0
241.38
263.45
mg/l
—
8
49
6
37
1.63
0.55
1.7
1.4
1.35
1.45
g/l
—
6
37
7
45
1.56
0.49
1.1
1.0
—
—
—
0
0
59
674
0.86
0.48
1.7
1.7
—
—
—
0
0
91
1008
0.89
0.47
1.7
2.0
1.52
1.52
%
0.00
86
914
5
31
1.62
0.43
1.4
1.1
—
—
—
0
0
14
105
1.34
0.41
1.6
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
17
0.00
0.40
0.0
2.4
—
120.18
—
0
17
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
161
1513
1.09
0.38
2.6
2.3
73.10
71.33
nmol/l
0.31
145
1394
27
230
1.18
0.31
3.2
2.8
—
—
—
0
0
23
195
1.19
0.28
3.3
2.8
—
—
—
0
0
379
3703
1.06
0.27
2.9
3.1
—
—
—
0
0
54
491
1.11
0.27
8.1
6.3
—
—
—
0
0
14
113
1.24
0.27
1.1
1.3
—
—
—
0
0
85
909
0.93
0.25
3.0
3.3
1.02
1.02
kg/l
0.02
13
113
27
236
1.15
0.24
1.3
1.2
—
—
—
0
0
378
3701
1.05
0.24
3.8
3.1
60.69
48.22
u/l
1.39
363
3526
5
40
1.25
0.22
1.2
1.4
86.20
88.55
umol/l
—
5
40
17
144
1.19
0.22
1.1
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
25
220
1.14
0.21
2.3
2.2
42.85
39.21
u/l
0.26
20
197
0
12
0.00
0.21
0.0
1.2
—
173.71
—
0
7
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
142
1479
0.95
0.20
3.1
3.8
9.50
9.23
mmol/l
0.21
115
1291
85
803
1.07
0.20
1.8
1.7
445.88
35756227.60
pmol/l
0.98
66
688
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
8
73
1.10
0.15
1.5
1.2
—
—
—
0
0
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
98
1011
0.96
0.10
1.5
1.5
—
—
—
0
0
10
87
1.15
0.09
1.2
1.1
—
—
—
0
0
122
1190
1.03
0.09
1.8
1.7
1.56
1.54
mmol/l
0.08
99
1017
14
127
1.10
0.08
1.1
1.6
—
—
—
0
0
8
75
1.07
0.07
1.0
1.2
—
—
—
0
0
15
162
0.92
0.06
1.1
1.3
215.25
171.90
miu/ml
—
8
70
13
139
0.93
0.03
1.7
2.2
75.65
123.47
ug/min
—
8
79
26
269
0.97
0.02
9.5
8.9
24.14
24.26
mmol/l
0.07
26
256
14
133
1.05
0.01
2.1
2.5
13.05
10.76
mg/l
0.46
14
125
14
136
1.03
0.00
1.0
1.1
—
—
—
0
0
12
119
1.01
0.00
5.1
1.3
0.26
0.23
g/l
0.46
12
113
129
1293
1.00
0.00
3.8
4.2
10.14
11.11
mg/mmol
0.09
83
891
19
191
0.99
0.00
1.5
1.7
—
230.00
—
0
6
22
221
1.00
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
3.25
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
-0.00
0.0
1.4
—
83.00
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
2.0
6.4
—
—
—
0
0
7
72
0.97
-0.00
1.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
60
1.00
-0.00
1.7
1.2
—
—
—
0
0
8
89
0.90
-0.00
1.0
1.3
12.00
16.55
u/l
—
8
79
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
12
120
1.00
-0.00
5.1
1.4
1.26
1.16
g/l
0.52
12
114
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.4
2.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TESTIS – Malignant neoplasm of testis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).